A previous blog post discussed an ongoing trial (Keynote-028) of a promising new treatment for mesothelioma. The study aimed to examine the effects of Keytruda, a checkpoint inhibitor immunotherapy drug, on patients with mesothelioma. The U.S. Food and Drug Administration has now approved Keytruda for treatment of advanced or metastatic urothelial carcinoma, bringing it one step closer to becoming an approved treatment option for those with mesothelioma.
Wrongful death suits for secondhand asbestos victims
What are asbestos trust funds?
Over four decades ago, it was established that companies were using asbestos in their products despite their knowledge of its lethal health risks. As more people began to file lawsuits and companies were unable to satisfy their financial liabilities, asbestos trust funds were created.
Mesothelioma: symptoms and risk factors
Thousands of people are diagnosed with mesothelioma each year. The latency period for mesothelioma is particularly long. Consequently, it has decades to establish itself in the body before disease diagnosis and treatment.
